These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel CLDN16 mutation in familial hypomagnesemia with hypercalciuria and nephrocalcinosis . Zhang H, Ling C, Liu X. Clin Nephrol; 2019 Aug; 92(2):95-97. PubMed ID: 31232269 [Abstract] [Full Text] [Related]
4. Retrospective cohort study of familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations. Sikora P, Zaniew M, Haisch L, Pulcer B, Szczepańska M, Moczulska A, Rogowska-Kalisz A, Bieniaś B, Tkaczyk M, Ostalska-Nowicka D, Zachwieja K, Hyla-Klekot L, Schlingmann KP, Konrad M. Nephrol Dial Transplant; 2015 Apr; 30(4):636-44. PubMed ID: 25477417 [Abstract] [Full Text] [Related]
5. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family. Yuan T, Pang Q, Xing X, Wang X, Li Y, Li J, Wu X, Li M, Wang O, Jiang Y, Dong J, Xia W. Calcif Tissue Int; 2015 Apr; 96(4):265-73. PubMed ID: 25555744 [Abstract] [Full Text] [Related]
11. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Perdomo-Ramirez A, Aguirre M, Davitaia T, Ariceta G, Ramos-Trujillo E, RenalTube Group, Claverie-Martin F. Gene; 2019 Mar 20; 689():227-234. PubMed ID: 30576809 [Abstract] [Full Text] [Related]
14. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, Couzi L, Barrou B, Godin M, Chauveau D, Faguer S, Vallet M, Cochat P, Eckart P, Guest G, Guigonis V, Houillier P, Blanchard A, Jeunemaitre X, Vargas-Poussou R. Clin J Am Soc Nephrol; 2012 May 20; 7(5):801-9. PubMed ID: 22422540 [Abstract] [Full Text] [Related]
15. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene. Hampson G, Konrad MA, Scoble J. BMC Nephrol; 2008 Sep 24; 9():12. PubMed ID: 18816383 [Abstract] [Full Text] [Related]
16. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease. Naeem M, Hussain S, Akhtar N. Am J Nephrol; 2011 Sep 24; 34(3):241-8. PubMed ID: 21791920 [Abstract] [Full Text] [Related]
18. Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. García-Castaño A, Perdomo-Ramirez A, Vall-Palomar M, Ramos-Trujillo E, Madariaga L, Ariceta G, Claverie-Martin F. Mol Genet Genomic Med; 2020 Nov 24; 8(11):e1475. PubMed ID: 32869508 [Abstract] [Full Text] [Related]